Down's syndrome-associated Single Minded 2 gene as a pancreatic cancer drug therapy target

Cancer Letters

Volumn 200, Issue 1, 2003, Pages 25-31

  DeYoung, Maurice Phil ^a   Tress, Matthew ^a   Narayanan, Ramaswamy ^a  

^a FLORIDA ATLANTIC UNIVERSITY   (United States)

Author keywords

Antisense; Apoptosis; Bioinformatics; Cancer Genome Anatomy Project database; Cancer therapy; Gene regulation; Human genome; Solid tumors

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE;

APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL DEATH; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN SYNDROME; DRUG EFFECT; DRUG SPECIFICITY; DRUG TARGETING; GENE; GENE CONTROL; GENE EXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MULTIGENE FAMILY; PANCREAS CANCER; PRIORITY JOURNAL; SINGLE MINDED 2 GENE;

EID: 0141863174     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(03)00409-9     Document Type: Article

References (18)

1. Riggins G.J., Strausberg R.L. Genome and genetic resources from the Cancer Genome Anatomy Project. Hum. Mol. Genet. 10:2001;663-667.
2. Strausberg R.L., Dahl C.A., Klausner R.D. New opportunities for uncovering the molecular basis of cancer. Nat. Genet. 15:(Spec No.):1997;415-416.
3. DeYoung M.P., Damania H., Scheurle D., Zylberberg C., Narayanan R. Bioinformatics-based discovery of a novel factor with apparent specificity to colon cancer. In Vivo. 16:2002;239-248.
4. Scheurle D., DeYoung M.P., Binninger D.M., Page H., Jahanzeb M., Narayanan R. Cancer gene discovery using digital differential display. Cancer Res. 60:2000;4037-4043.
5. McCormick M.K., Schinzel A., Petersen M.B., Stetten G., Driscoll D.J., Cantu E.S., Tranebjaerg L., Mikkelsen M., Watkins P.C., Antonarakis S.E. Molecular genetic approach to the characterization of the "Down syndrome region" of chromosome 21. Genomics. 5:1989;325-331.
6. Chrast R., Scott H.S., Chen H., Kudoh J., Rossier C., Minoshima S., Wang Y., Shimizu N., Antonarakis S.E. Cloning of two human homologs of the Drosophila single-minded gene SIM1 on chromosome 6q and SIM2 on 21q within the Down syndrome chromosomal region. Genome Res. 7:1997;615-624.
7. Isaac D.D., Andrew D.J. Tubulogenesis in Drosophila: a requirement for the trachealess gene product. Genes Dev. 10:1996;103-117.
8. Nambu J.R., Lewis J.O., Wharton K.A. Jr, Crews S.T. The Drosophila single-minded gene encodes a helix-loop-helix protein that acts as a master regulator of CNS midline development. Cell. 67:1991;1157-1167.
9. Thomas J.B., Crews S.T., Goodman C.S. Molecular genetics of the single-minded locus: a gene involved in the development of the Drosophila nervous system. Cell. 52:1988;133-141.
10. De Young M.P., Scheurle D., Damania H., Zylberberg Z., Narayanan R. Down's Syndrome-associated Single Minded Gene as a novel tumor marker. Anticancer Res. 22:2002;3149-3158.
11. DeYoung M.P., Tress M., Narayanan R. Identification of a Down's syndrome critical locus gene SIM2-s as a drug therapy target for solid tumors. Proc. Natl. Acad. Sci. USA. 100:2003;4760-4765.
12. Kola I., Hertzog P.J. Animal models in the study of the biological function of genes on human chromosome 21 and their role in the pathophysiology of Down syndrome. Hum. Mol. Genet. 6:1997;1713-1727.
13. Kola I., Hertzog P.J. Down syndrome and mouse models. Curr. Opin. Genet. Dev. 8:1998;316-321.
14. Satge D., Sommelet D., Geneix A., Nishi M., Malet P., Vekemans M. A tumor profile in Down syndrome. Am. J. Med. Genet. 78:1998;207-216.
15. Abbot D.W., Freeman M.L., Holt J. Double-strand break repair efficiency and radiation sensitivity in BRCA2 mutant cancer cells. J. Natl. Cancer Inst. 90:1998;6-13.
16. Goggins M., Schutte M., Lu J., Moskaluk C.A., Weinstein C.L., Peterson G.M., Yeo C.J., Jackson L.E., Lynch H.T., Hrubin R.H., Kern S.E. Germline BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas. Cancer Res. 56:1996;5360-5364.
17. Yuan S.F., Lee S.Y., Chien G., Song M., Tomlinson G.E., Lee E.Y.-H.P. BRCA2 is required for ionizing radiation-induced assembly of Rad51 complex in vivo. Cancer Res. 59:1999;3547-3551.
18. Elnemr A., Ohta T., Yachie A., Kayahara M., Kitagawa H., Ninomiya I., Fushida S., Fujimura T., Nishimura G., Shimizu K., Miwa K. Human pancreatic cancer cells express non-functional Fas receptors and counterattack lymphocytes by expressing Fas ligand; a potential mechanism for immune escape. Int. J. Oncol. 18:2001;33-39.